Glycoprotein conjugated vaccine (Glycovaxyn)

糖蛋白结合疫苗

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGlycoprotein conjugated vaccine (Glycovaxyn)
Drug Alias NameGroup B meningococcal vaccineUropathogenic E.Coli vaccineGlycoconjugate vaccinesStaphylococcus aureus vaccineGroup A Streptococcus conjugate vaccine
ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsStaphylococcal InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcLimmatech Biologics Ag
Active IndicationsN/A
Inactive IndicationsStaphylococcal InfectionsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A